GlassScriptPhysician profile
Sarah A Cada
NPI 1790714921
$1,516.05
in general payments reported to CMS, 2019-2025
22 companies · $307 in 2025
The $307 reported for 2025 was more than what 78% of Reproductive Endocrinology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $213 · 2020: $266 · 2021: $297 · 2022: $27.71 · 2023: $117 · 2024: $288 · 2025: $307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $712.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $711.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $380.86 | 2019-2025 | Liletta, Lo Loestrin Fe |
| Astellas Pharma US INC | $295.62 | 2023-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $212.11 | 2019-2025 | |
| Exeltis, USA INC. | $67.21 | 2021-2025 | Slynd |
| Coopersurgical, INC. | $63.47 | 2020-2025 | Paragard T 380a, Paragard T 380a |
| Hologic Sales and Service, LLC | $58.72 | 2024-2025 | Acessa Provu System, Sonata Sonography-Guided Transcervical Fibroid Ablation System, Novasure |
| Novo Nordisk INC | $57.85 | 2020-2024 | Wegovy |
| Pfizer INC. | $56.82 | 2021-2024 | |
| Therapeuticsmd, INC. | $49.00 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $38.97 | 2019-2020 | |
| Amgen INC. | $38.05 | 2019-2024 | Prolia, Evenity |
| Lupin INC. | $25.66 | 2020 | |
| Duchesnay USA Incorporated | $22.88 | 2019 | |
| Sumitomo Pharma America, INC. | $21.03 | 2025 | Myfembree |
| Biogen, INC. | $19.88 | 2024 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $19.88 | 2020 | |
| Organon LLC | $19.40 | 2021 | |
| Argon Medical Devices, INC. | $17.53 | 2019 | |
| Daiichi Sankyo INC. | $15.22 | 2021 | |
| Lilly USA, LLC | $13.90 | 2021 | |
| Amag Pharmaceuticals, INC. | $11.14 | 2020 | |
| Covidien LP | $10.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Cada listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.